CUAMC
URGN icon

China Universal Asset Management Company’s UroGen Pharma URGN Stock Holding History

China Universal Asset Management Company’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
7,754
-553
-7% -$15K 0.02% 326
2026
Q1 		$149K Buy
8,307
+680
+9% +$13.6K 0.01% 375
2025
Q4 		$179K Sell
7,627
-482
-6% -$10.5K 0.01% 354
2025
Q3 		$162K Sell
8,109
-1,152
-12% -$20.7K 0.01% 346
2025
Q2 		$127K Buy
9,261
+797
+9% +$7.65K 0.01% 344
2025
Q1 		$93.6K Sell
8,464
-484
-5% -$5.16K 0.01% 362
2024
Q4 		$95.3K Buy
8,948
+848
+10% +$10.2K 0.01% 396
2024
Q3 		$103K Buy
8,100
+3,856
+91% +$57.2K 0.01% 355
2024
Q2 		$71.2K Sell
4,244
-1,659
-28% -$23.6K 0.01% 326
2024
Q1 		$88.5K Buy
5,903
+2,328
+65% +$38.1K 0.01% 383
2023
Q4 		$53.6K Buy
3,575
+2,801
+362% +$36.4K 0.01% 365
2023
Q3 		$10.8K Buy
774
+467
+152% +$7.5K ﹤0.01% 340
2023
Q2 		$3.18K Sell
307
-6
-2% -$66 ﹤0.01% 405
2023
Q1 		$2.89K Buy
313
+79
+34% +$727 ﹤0.01% 416
2022
Q4 		$2.08K Buy
234
+21
+10% +$199 ﹤0.01% 370
2022
Q3 		$2K Buy
+213
New +$1.76K ﹤0.01% 361

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

China Universal Asset Management Company's URGN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its UroGen Pharma (URGN) stake by 6.7% in Q2 2026, selling an estimated $15K and leaving 7,754 shares worth $285K. The position accounts for 0.02% of the portfolio, ranked #326.

China Universal Asset Management Company first reported a position in URGN in Q3 2022 and has held it in 16 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • China Universal Asset Management Company held 7,754 shares of UroGen Pharma worth $285K as of Q2 2026.
  • China Universal Asset Management Company sold 553 UroGen Pharma shares in Q2 2026, an estimated $15K.
  • UroGen Pharma made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #326 holding.
  • China Universal Asset Management Company first reported a position in UroGen Pharma in Q3 2022 and has held it in 16 quarters since.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.